Literature DB >> 22227247

SnoN oncoprotein enhances estrogen receptor-α transcriptional activity.

Arja M Band1, Marikki Laiho.   

Abstract

Estrogen receptor-α (ERα) and transforming growth factor-beta (TGF-β) signaling pathways are essential regulators during mammary gland development and tumorigenesis. Ski-related novel gene (SnoN) is an oncoprotein and a negative feedback inhibitor of TGF-β signaling. We have previously reported that low expression of SnoN in ERα positive breast carcinomas is associated with favorable prognosis (Zhang et al. Cancer Res. (2003) 63, 5005-5010). Here we have studied the mechanism of a possible cross-talk between ERα and SnoN. We find that SnoN interacts with the estrogen-activated form of ERα in the nucleus. SnoN contains two highly conserved nuclear receptor binding LxxLL-like motifs and we show that mutations in these motifs reduce the interaction of SnoN with ERα. Over-expression of SnoN enhanced the transcriptional activity of ERα in estrogen response element (ERE)-reporter assays, augmented the expression of several ERα target genes and increased the proliferation of MCF7 breast carcinoma cells in an estrogen-dependent manner. Chromatin immunoprecipitation demonstrated that SnoN interacts with ERα at the TTF1 (pS2) gene promoter. Conversely, silencing of SnoN reduced both ERE-reporter activity and the expression of ERα target genes in MCF7 and T-47D breast cancer cells. Histone deacetylase inhibition increased the level of SnoN and SnoN-dependent enhancement of ERα-dependent transcription and SnoN supported the recruitment of p300 histone acetylase to ERα. This study reveals a novel mechanism that interconnects ERα and TGF-β signaling pathways by SnoN. Accordingly, the results indicate that high SnoN level promotes ERα signaling and possibly breast cancer progression.
Copyright © 2012 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22227247      PMCID: PMC3612938          DOI: 10.1016/j.cellsig.2011.12.015

Source DB:  PubMed          Journal:  Cell Signal        ISSN: 0898-6568            Impact factor:   4.315


  38 in total

1.  Cytoplasmic SnoN in normal tissues and nonmalignant cells antagonizes TGF-beta signaling by sequestration of the Smad proteins.

Authors:  Ariel R Krakowski; Julien Laboureau; Alain Mauviel; Mina J Bissell; Kunxin Luo
Journal:  Proc Natl Acad Sci U S A       Date:  2005-08-18       Impact factor: 11.205

Review 2.  How the Smads regulate transcription.

Authors:  Sarah Ross; Caroline S Hill
Journal:  Int J Biochem Cell Biol       Date:  2007-10-07       Impact factor: 5.085

3.  c-Ski activates MyoD in the nucleus of myoblastic cells through suppression of histone deacetylases.

Authors:  Norihiko Kobayashi; Kouichiro Goto; Kana Horiguchi; Motoko Nagata; Mikiko Kawata; Keiji Miyazawa; Masao Saitoh; Kohei Miyazono
Journal:  Genes Cells       Date:  2007-03       Impact factor: 1.891

4.  Dual role of SnoN in mammalian tumorigenesis.

Authors:  Qingwei Zhu; Ariel R Krakowski; Elizabeth E Dunham; Long Wang; Abhik Bandyopadhyay; Rebecca Berdeaux; G Steven Martin; LuZhe Sun; Kunxin Luo
Journal:  Mol Cell Biol       Date:  2006-10-30       Impact factor: 4.272

Review 5.  TGFbeta in Cancer.

Authors:  Joan Massagué
Journal:  Cell       Date:  2008-07-25       Impact factor: 41.582

Review 6.  Signaling by estrogens.

Authors:  Boris J Cheskis; James G Greger; Sunil Nagpal; Leonard P Freedman
Journal:  J Cell Physiol       Date:  2007-12       Impact factor: 6.384

Review 7.  Ski and SnoN, potent negative regulators of TGF-beta signaling.

Authors:  Julien Deheuninck; Kunxin Luo
Journal:  Cell Res       Date:  2009-01       Impact factor: 25.617

Review 8.  Non-classical genomic estrogen receptor (ER)/specificity protein and ER/activating protein-1 signaling pathways.

Authors:  Stephen Safe; Kyounghyun Kim; Kyoungkim Kim
Journal:  J Mol Endocrinol       Date:  2008-09-04       Impact factor: 5.098

9.  A SnoN-Ccd1 pathway promotes axonal morphogenesis in the mammalian brain.

Authors:  Yoshiho Ikeuchi; Judith Stegmüller; Stuart Netherton; Mai Anh Huynh; Masayuki Masu; David Frank; Shirin Bonni; Azad Bonni
Journal:  J Neurosci       Date:  2009-04-01       Impact factor: 6.167

10.  Endocrinology and hormone therapy in breast cancer: new insight into estrogen receptor-alpha function and its implication for endocrine therapy resistance in breast cancer.

Authors:  Rachel Schiff; C Kent Osborne
Journal:  Breast Cancer Res       Date:  2005-07-20       Impact factor: 6.466

View more
  8 in total

1.  Chemotherapeutic Targeting of the Transforming Growth Factor-β Pathway in Breast Cancers.

Authors:  Yong-Hun Lee; William P Schiemann
Journal:  Breast Cancer Manag       Date:  2014

Review 2.  SnoN signaling in proliferating cells and postmitotic neurons.

Authors:  Shirin Bonni; Azad Bonni
Journal:  FEBS Lett       Date:  2012-03-08       Impact factor: 4.124

3.  Recurrent SKIL-activating rearrangements in ETS-negative prostate cancer.

Authors:  Matti Annala; Kati Kivinummi; Joonas Tuominen; Serdar Karakurt; Kirsi Granberg; Leena Latonen; Antti Ylipää; Liisa Sjöblom; Pekka Ruusuvuori; Outi Saramäki; Kirsi M Kaukoniemi; Olli Yli-Harja; Robert L Vessella; Teuvo L J Tammela; Wei Zhang; Tapio Visakorpi; Matti Nykter
Journal:  Oncotarget       Date:  2015-03-20

4.  The influence of SnoN gene silencing by siRNA on the cell proliferation and apoptosis of human pancreatic cancer cells.

Authors:  Chengli Liu; Hui Zhang; Xiaoxia Zang; Cheng Wang; Yalin Kong; Hongyi Zhang
Journal:  Diagn Pathol       Date:  2015-04-18       Impact factor: 2.644

5.  Herbal compound 861 prevents hepatic fibrosis by inhibiting the TGF-β1/Smad/SnoN pathway in bile duct-ligated rats.

Authors:  Cheng Chi; Xiao-Ya Liu; Fei Hou; Xiao-Zheng Yu; Chun-Yun Li; Li-Jian Cui; Rui-Xia Liu; Cheng-Hong Yin
Journal:  BMC Complement Altern Med       Date:  2018-02-05       Impact factor: 3.659

6.  Regulation of estrogen receptor signaling in breast carcinogenesis and breast cancer therapy.

Authors:  Zhuan Zhou; Joe X Qiao; Amit Shetty; George Wu; Yi Huang; Nancy E Davidson; Yong Wan
Journal:  Cell Mol Life Sci       Date:  2014-04       Impact factor: 9.207

7.  Transcriptional cofactors Ski and SnoN are major regulators of the TGF-β/Smad signaling pathway in health and disease.

Authors:  Angeles C Tecalco-Cruz; Diana G Ríos-López; Genaro Vázquez-Victorio; Reyna E Rosales-Alvarez; Marina Macías-Silva
Journal:  Signal Transduct Target Ther       Date:  2018-06-08

Review 8.  The role of Anaphase Promoting Complex activation, inhibition and substrates in cancer development and progression.

Authors:  Cordell VanGenderen; Troy Anthony Alan Harkness; Terra Gayle Arnason
Journal:  Aging (Albany NY)       Date:  2020-08-15       Impact factor: 5.682

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.